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The extract of Geitlerinema carotinosum CNP 4003 showed promising antimicrobial activity (100 and 1000 µg/disc/well) 
against E. coli ATCC 35218, S. aureus ATCC 25923, and M. smegmatis with inhibition zones of 6, 8, and 11 mm, respectively. 
In addition, the extract also exhibited cytotoxic activity (IC50 = 175 μg/ml) against mammalian (HepG2) liver cancer cell lines. 
Therefore, the crude extract was fractionated using column chromatography technique and the active fractions were identified. 
The active fractions tested against HepG2 cell line showed 95 % hemolytic activity at the concentration of 375 µg/ml with IC50 
as 63 μg/ml. Further, the compounds in the active fractions were analyzed and the results indicated the presence of indoles, 
terpenes, and peptides. The chemical composition of the active fraction was analyzed by using gas chromatography-mass 
spectrometry (GC-MS). The potential antimycobacterial strain G. carotinosum CNP 4003 was confirmed by molecular 
characterization and the DNA sequence was deposited in the gene bank.  
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Introduction 
Tuberculosis (TB) is a precarious and 
communicable bacterial infection that causes 
considerable socioeconomic and public health 
problems in developing countries. Members of the 
Mycobacterium species such as Mycobacterium bovis, 
M. africanum, M. tuberculosis, M. pinnipedii,  
M. canettii, and M. microti are the main causative 
agents of TB causing significant health losses in human 
beings1. Around the world, M. tuberculosis is the 
predominant species to cause TB. M. tuberculosis is 
frequently developing resistance against all first- and 
second-line drugs like isoniazid, rifampicin, 
ethambutol, streptomycin, pyrazinamide, amino-
glycosides, and fluoroquinolones2. Therefore, it is a 
vital requirement to find out novel medicines through 
valuable antimycobacterial action which is 
commercially viable, and eco-friendly. Various 
infectious diseases are known to be treated by natural 
products throughout the history of mankind3. 
Among the mycobacterium species, M. smegmatis is 
classified as saprophytic, relatively safe, and incapable 
of causing disease and doesn't usually cause disease in 
any humans4. Further, due to its properties such as non 
virulence, fast grower or fast doubling time and 
similarities with M. tuberculosis (> 2000 common 
homologs; unusual cell wall structure that can oxidize 
carbon monoxide aerobically), it has become the 
simple model for TB. In modern times, several new 
species belonging to this genus (M. avium, M. leprea, 
M. bovis, and M. tuberculosis) are identified as virulent 
that cause TB and leprosy. Therefore, non virulent 
bacteria of this type are necessary to tackle the 
mycobacerium associated health problems. In the 
majority cases, M. smegmatis is used as secure and a 
virulent alternative5. One of our earlier reports 
emphasized the efficacy of ethyl acetate extract (from 
the Oscillatoria laetevirens BDU 141071) activity 
against M. smegmatis6.  
Extracts from Spirulina platensis isolated from an 
Egyptian water station has been accounted to hold 
anti-bacterial properties. Methanolic and aqueous 
extracts from the powder of cyanobacterial culture 
were found to possess action beside Streptococcus 
faecalis, Salmonella typhimurium and Escherichia 
coli 100 % (0.3 mg/ml), 86.2 % (0.5 mg/ml) and 91.6 
% (0.7 mg/ml) from MeOH and 72.6 % (0.1 mg/ml), 
99.3 % (0.9 mg/ml) and 74.4 % (0.9 mg/ml) from 
aqueous extracts)7. Murugan8 reported excellent 
activity of sodium phosphate buffer extracts of  




S. platensis (C-phycocyanin) against Klebsiella 
pneumonia, Bacillus subtilis, E. coli, Staphylococcus 
aureus (11, 11, 6, and 12 mm of inhibition zone, 
respectively at 30 μg/disc). Also, aqueous extracts of 
Oscillatoria sp. showed activity against Streptococcus 
mutants (20 mm of zone at 750 μg/ml)9. Crude 
extracts of Lyngbya aestuarii and Oscillatoria 
boryana inhibited the growth of three of the 
pathogens, E. coli, Enterobacter aerogenes and 
Salmonella typhi10. 
The hexane extract of Trichodesmium erythraeum 
exhibited antifungal activity against Trichophyton 
simii (31.25 µg/ml) and T. rubrum,  
T. mentagrophytes, Aspergillus flavus, A. niger, 
Scopulariopsis sp, and Botrytis cinerea at 1000 
µg/ml11. Ethyl acetate extract of Phormidium 
valderianum exhibited anticandidal activity at the 
concentration of 0.5 mg/disc against Candida 
albicans12. Frankmölle et al.13 demonstrated a 
moderate antifungal action of crude ethanolic extracts 
of Anabaena laxa on Aspergillus oryzae and  
C. albicans (26 and 19 mm of inhibition zone at > 10 
μg/ml). Further, the methanolic extracts of  
L. aestuarii showed a reasonable antifungal action to 
C. albicans14.  
Freshwater, terrestrial and marine cyanobacteria 
(blue-green algae) have been identified as one of the 
promising groups of organisms to produce bioactive 
metabolites mainly of cytotoxins, enzyme inhibitors, 
antiparasitic, allelopathic, antimicrobial and AF 
compounds15. The exploration of cyanobacterial 
biodiversity in the marine environment and its 
associated bioactive metabolites diversity has resulted 
clinical development of new marine bioactive 
substances. Till date, several potent compounds 
isolated from different species of marine 
cyanobacteria having potent activity against bacteria, 
fungi, and mycobacterium (Table S1). In these work, 
antimicrobial activities of cyanobacterial extract was 
tested on pathogenic bacteria and fungi. Further, the 
extracts were tested for mammalian toxicity by in 
vitro test (red blood cell toxicity or HepG2 cells). 
Then various columns chromatographic techniques 
were used to partially purify the active extracts. 
Subsequently, thin-layer chromatography (TLC) and 
gas chromatography-mass spectrometry (GC-MS) 
were used for active fraction analysis. At last, the 
potential antimicrobial metabolite generating 
cyanobacteria was identified and described by 16S 
rRNA analysis. 
Materials and Methods 
 
Collection, isolation, identification, cultivation of cyanobacteria, 
and extract preparation  
Marine cyanobacteria strains were isolated, 
cultivated in ASN-III medium and identified by using 
light microscope (Olympus CH20i) at 100X 
magnification16. Strains were kept at 27±2 °C, in a 
light (intensity of 36.45 μmol/m2/s1; illuminated by 
cold white fluorescent tubes) and dark cycle of 14 h 
and 10 h, respectively17. After the incubation, cells 
were harvested and extracts were obtained by the cold 
extraction method. The solvent extracts were 
centrifuged at 10000 rpm for 10 min and the 
recovered supernatant was subsequently dried and 
stored at −20 °C. Thus, obtained crude extracts of the 
cyanobacterial strains were dissolved in DMSO for 
antimicrobial assay. 
 
Phylogenetic analysis of 16S rRNA gene and amplification by 
PCR 
The polymerase chain reaction (PCR) was used for 
amplifying the 16S rRNA gene of the isolated DNA 
of Geitlerinema carotinosum (Geitler) Anagnostidis 
CNP 4003. CYA106F (5ʹ CGG ACG GGT GAG 
TAA CGC GTG A 3ʹ) and CYA781 (R)b (5ʹ GAC 
TAC TGG GGT ATC TAA TCC CAT T 3ʹ) primers 
were used as illustrated earlier by Maruthanayagam et 
al.18. The PCR quantities were detained 30 µl having 
10 µl of Milli-Q water, one ml of each primer  
(10 pmol/ml), 16 µl of PCR mixture 2X Master Mix 
(Prime), and two µl (& 20 ng) of DNA. My gene 
thermocycler (Applied Biosystems, Foster City, CA) 
was used for PCR amplification with the following 
conditions: four min at 94 °C for initial denaturation; 
35 cycles of denaturation at 94 °C for four min, 
annealing at 50 °C for one minute, and extension at  
72 °C for 1.3 min; followed by seven minutes of final 
extension at 72 °C. Agarose gel electrophoresis  
(1.2 %) and RPC purification kit (Real Biotech 
Corporation (RBC), Bangiao City, Taiwan) were used 
to confirm the PCR products (589 bp DNA) and their 
purity, respectively. Reverse and forward primers were 
used for sequencing the gene. The BLAST system was 
used for analyzing the 16S rRNA gene sequences to 
identify their closest relatives. The public domain 
GenBank database was used for the gene sequence 
deposition. ClustalW multiple alignment algorithms 
were used for multiple alignments and created with 
reference to the selected GenBank sequences. In the 
analysis of alignment positions, sequences with one or 
more gaps or ambiguities were omitted. Neighbor-




joining method and the bootstrap method of phylogeny 
with 1500 replications were used for determining the 
evolutionary history using MEGA 5.0(ref. 19). The entire 
place enclosed gaps and missing data were removed. 
 
Antimicrobial screening test 
Antimicrobial activities of extracts were screened 
against the bacterial strains S. aureus ATCC 25923, M. 
smegmatis (National Institute of Research in 
Tuberculosis, Chennai, India), Pseudomonas 
aeruginosa ATCC 27853, Klebsiella pneumoniae 
ATCC 17106, E. coli ATCC 35218, and a fungal 
pathogen, C. albicans ATCC 10028. The nutrient agar 
and Sabouraud dextrose agar were used to maintain the 
bacterial and fungal cultures, respectively. About 0.85 
% NaCl was used for suspending the microbial strains 
and the turbidity was adjusted to 108 CFU/ml, 
equivalent to 0.5 MacFarland standards according to 
NCCLS. Using the non-toxic cotton swab, the cell 
suspension was inoculated onto agar and incubated for 
20 min at 37 °C). Each crude/fractionated extract was 
estimated mostly by the disc or well diffusion assay 
according to Kirby-Bauer method20. For the purpose, 
each those extracts were individually suspended in 
sterilized DMSO at the concentration of 100 µg or 1 
mg and then loaded on to 6-mm Whatman No. 3 filter 
disc (at a concentration of 100 µg/disc) or well. DMSO 
was used as a control solvent. Thereafter, those extract 
spotted plates (were incubated (37 °C, 24 h) and the 
antimicrobial potential was assessed based on the zone 
of inhibition (millimeters).  
 
Silica gel column chromatography 
The silica gel (100-200 mesh) was prepared and the 
active fraction was loaded, and separated by the 
solvent gradient. The collected fractions were spotted 
in the in house prepared TLC plates (0.25-mm) and 
kept in the developing chamber (30 % EtoAC: 70 % 
PE). After developing the plates, 5 % H2SO4: 
methanol solution was sprayed on it. Then the plates 
were placed in the iodine chamber and heated in hot 
air oven to remove the excess iodine vapor and finally 
to observe the spot in UV Transilluminator. As 
observed, they were similar in composition, as shown 
by thin-layer chromatography, and combined and 
dried. The active fraction with antimycobacterial 
activity against M. smegmatis was selected and used 
for further analysis. 
 
Evaluation of minimal inhibitory concentration by broth 
macro dilution method 
The minimal inhibitory concentration (MIC) was 
analyzed by using fraction 6 to determine the least 
concentration of the active fraction that can cause 
noticeable growth inhibition and bactericidal effects 
against the M. smegmatis. A fresh colony of M. 
smegmatis was inoculated in nutrient broth and grown 
with vigorous aeration for overnight at 37 ºC. Ten 
(10) µl of the mid-exponential culture (1×106 
cells/ml) were mixed with the active fraction 
dissolved in methanol at concentrations of 50 – 3000 
µg in one ml total volume of nutrient broth and 
incubated at 37 ºC for 24 h with gentle agitation. 
After incubation, the culture pellets were gained by 
centrifugation at 10000 rpm (REMI Cooling 
Centrifuge 24 BL) and re-suspended in 0.1 ml saline, 
and the whole suspension was swabbed onto the 
respective agar plates and allowed to grow for a 
further 24 – 48 h at 37 ºC and then the MIC and MBC 
were determined21.  
 
In vitro cytotoxic assay using marine cyanobacterial extracts 
The HepG2 human liver cancer cell line obtained 
from the National Center for Cell Science (NCCS), 
Pune, India, was used to estimate the toxicity of 
cyanobacterial extract by using MTT (3-(4,5-di-
methylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium 
bromide) assay22. DMEM medium (Sigma-Aldrich, 
St. Louis, MO, USA) (10 % fetal bovine serum 
(Gibco) and 100 U/ml of penicillin and 100 μg/ml of 
streptomycin as antibiotics (Gibco)) was used for the 
cultivation of HepG2 cells in 96 well plates at 37 °C 
in a humidified atmosphere of 5 % CO2 in a 
CO2 incubator (Forma, Thermo Scientific, USA). 
Cells from passage 15 or less were used for the entire 
experimentation. Briefly, 96-well flat-bottom tissue-
culture plates in the complete culture medium for 
cells [(5×103 cells (200 μl/well)] seeding. After 
overnight-seeding, the extracts were added and 
incubated for 24 hrs in the same CO2 incubator. 
DMSO (10 %) added well was used as a positive 
control. About 20 μl of MTT solution [5 mg/ml in 
phosphate-buffered saline (PBS)] was added to each 
well after 24 and 48 h, covered with aluminum foil 
and incubated for 4 h at 37 °C. After the incubation, 
100 μl of DMSO was added to each well to suspend 
the purple formazan product. The 96-well plate reader 
(Bio-Rad, Hercules, CA, USA) was used to measure 
the absorbance at 570 nm (measurement) and 630 nm 
(reference). Mean of the three replicates were used to 
calculate the percentage of inhibition as follows: 
Percentage of Inhibition = (Mean OD of untreated 
cells (control) - Mean OD of treated cells (treat))/ 
Mean absorbance of untreated cells (control).  




Spector et al.23 were described as the acridine 
orange and ethidium bromide staining. About 25 μl of 
AO and EB solution (3.8 μM of AO and 2.5 μM of 
EB in PBS) was added to the each cell suspension 
(5×105 cells) and observed under a fluorescent 
microscope (Carl Zeiss, Germany) with a UV filter 
(450 - 490 nm). Three hundred cells per sample were 
counted in triplicate for each dose point. In addition, 
the morphological alteration was photographed. 
 
Hemolytic Assay 
Sodium citrate-EDTA containing centrifuge tubes 
(15 ml capacity) were used to collect human blood 
samples. After the collection, blood was transferred to 
a 50 ml centrifuge tube. To the blood, 30 ml of 
calcium- and magnesium-free PBS was added and 
centrifugation at 4000 rpm for 10 min until 
supernatant turned clear and colorless. The 
supernatant was discarded and the procedure was 
repeated twice to obtain clean cells. These cells were 
kept in PBS (20 ml) and used within 2 weeks. To the 
0.5 ml cell suspension in PBS, 5 ml of the test 
material from a stock solution was added. The number 
of compounds 93.75, 187.5, 375, 750, 1500, and 3000 
µg (final erythrocyte concentration approx. 
0.5×109/ml) were used for testing. The mixture was 
incubated for one hour at 37 ºC with mild shaking and 
then centrifuged at 4000 rpm for 10 min. The 
obtained supernatant was diluted 10-fold with PBS 
and the optical density was measured at 540 nm. PBS 
or 0.1 % Triton X-100 (w/v in water) was used for 
calculating the 0 and 100 % lysis and the tests were 
performed in duplicate24. 
 
Phytochemical analysis  
 
TLC study and developing a solvent system  
Precoated silica gel G 60 F254 was purchased from 
Merck, Germany and the solvents used were of 
analytical grade. A solution of the active fraction at a 
concentration of 5 mg/100 µl was prepared in ethyl 
acetate. Using a capillary tube, the active fraction was 
loaded in the Silica gel 60F254 TLC plate and 
developed with solvent system Acetonitrile: Heptane: 
Chloroform (1:4.5:4.5 V/V/V) for satisfactory 
separation of the compounds. After the development 
of plates, they were air-dried and the numbers of spots 
were noted. Spots were observed by spraying with 
various spraying reagents as follows: Ehrlich's reagent 
(0.1 g of p-dimethyl aminobenzaldehyde in five ml of 
hydrochloric acid and methanol; plates heated for 20 
min at 50 °C) for sulfonamides, amines, indoles, and 
ergot alkaloids, Dragendorff's reagent (0.011 g and 
0.018 g dissolved in acetic acid and makeup into 10 
ml of distilled water) for alkaloids, ninhydrin (0.1 g of 
ninhydrin dissolved in 9.5 ml of pyridine and 0.5 ml 
of acetic acid, heated to 110 °C until reddish spots) 
spray for peptides, phenol (Folin-Ciocalteu) reagent 
for phenolic compounds, 10 % sodium hydroxide 
reagent for flavonoids, anisaldehyde-sulphuric acid 
(0.75 g of anisaldehyde dissolved in 12.5 ml of 
ethanol and 0.125 ml of concentrated sulphuric acid) 
for sterols and terpenes, and ferric chloride reagent  
(5 % in methanol) and potassium hydroxide reagent 
(10 % in methanol) for Anthraquinone.  
 
GC-MS analysis of active fraction 
The coupled GC-MS was used for analyzing the 
active fraction (1 mg/1 ml ethyl acetate). THERMO 
GC-TRACE ULTRA VER: 5.0 analyzer with a flame 
ionization detector was used for the separation of 
compounds and analysis. DB 35-MS capillary standard 
non-polar column (length = 30 m, diameter = 0.25 mm, 
film thickness = 0.25 μm) was used for separation in 
GC-MS. The carrier gas was helium and the total GC 
run time was 40.50 min. 70 °C was kept as the initial 
oven temperature and it was ramped at 10 °C/min until 
it reached 250 °C. The injector temperature was  
250 °C. Ethyl acetate was used as a solvent to separate 
the compounds in the extracts and the split ratio 1:10. 
(http://www.sisweb.com/software/ms/nist.htm). The 
closest match with the highest probability in the NIST 
Mass Spectral Library was recorded and interpreted. 
 
Results 
A total of 12 filamentous forms of marine 
cyanobacteria (Aphanocapsa littoralis Hansgirg CNP 
2022, Phormidium abronema Skuja CNP 2012, 
Oscillatoria annae van Goor CNP 1020, Anabaena 
circinalis Var. crassa Ghose CNP 2061, Synechococcus 
pevalekii Nag. CNP 7001, G. pseudacutissimum 
Geitler) Anagnostidis CNP 1019, Oscillatoria princeps 
Vaucher ex Gomont CNP 1014, Anabaena constricta 
(Szaffer) Geitler CNP 5007, Phormidium valderianum 
(Delp.) Gomont CNP 4011, Oscillatoria salina Biswas 
CNP 1006, G. carotinosum (Geitler) Anagnostidis 
CNP 4003 and O. boryana Bory ex Gomont BDU 
91451) belonging to the genera Phormidium, 
Oscillatoria, Aphanocapsa, Synechococcus, Anabaena, 
and Geitlerinema were taken for the initial screening. 
Classical methods based on morphology were used for 
identifying the strains (Desikachari, 1959) and  
G. carotinosum CNP 4003 (Fig. 1a) was further 
confirmed by phylogenetic analysis (Fig. 1c). 




Therefore, classification by 16S rRNA gene 
sequencing was reserved to find out the genus for 
certain cases. The PCR amplification of the 16S 
sequence of G. carotinosum CNP 4003 (Fig. 1b) 
resulted in 589 bp DNA and it was used for the 
BLAST search. The DNA isolated from this 
cyanobacterium exhibited sequence resemblance with 
the DNA of another cyanobacterium (accession 
number AJ621834) and the sequence was deposited in 
the GenBank database with accession number 
KC404068.  
In this study, organic crude extracts from the above 
listed cyanobacteria were screened (Table S2) for 
their antifungal and antibacterial activity against 
Candida, Gram-negative and Gram-positive strains of 
bacteria. Preliminary testing for the antimicrobial 
study of extracts was performed by the disc diffusion 
and agar well method. The best antibacterial activity 
was observed in the extract of G. carotinosum CNP 
4003 at 100 µg /disc and 1000 µg/well against  
S. aureus ATCC 25923, E. coli ATCC 35218, and  
M. smegmatis with inhibition zones of 6, 8, and 11 
mm, correspondingly (Fig. S1). The extract of  
G. carotinosum CNP 4003 showed the highest 
inhibition level against M. smegmatis. The 
cytotoxicity result (Fig. 2) revealed that the potent 
 
 
Fig. 1 — Morphology and molecular identification of G. carotinosum CNP 4003: (A) Microscopic image of G. carotinosum CNP 4003, (B) 
amplification product of G. carotinosum CNP 4003 16S rRNA (a - G. carotinosum CNP 4003, m -100 bp marker), and (C) phylogenetic tree 
 




extract of G. carotinosum CNP 4003 was moderately 
cytotoxic to mammalian cell line HepG2 (IC50 175 
μg/ml) with antimycobacterial activity against  
M. smegmatis at 1 mg/well. Furthermore, this extract 
was fractionated by silica gel chromatography and 
antimycobacterial activity was checked for 9 pooled 
fractions of C17 (F1-F9). Of all the tested fractions, 
fraction 6 showed the maximum inhibition activity at 
250 µg from per disc concentration with 8 mm of 
inhibition zone (Fig. S2). This fraction was chosen to 
determine the MIC. Fraction 6 was serially diluted  
50 to 3000 µg and MIC value was determined  
(Fig. S3). Further, the treated cells were collected and 
plated for viable count analysis. The results showed 
that the MBC and MIC of the fraction 6 was 800 and 
1500 µg as tested on the M. smegmatis strain. Very 
low hemolytic activity, i.e. 63 % (Fig. 3) was 
observed at 93.75 µg/ml, whereas the highest 
hemolysis (95 %) was observed at the concentration 
of 375 µg/ml. Further, the active fraction F6 was 
relatively cytotoxic to liver cell line HepG2 (IC50 63 
μg/ml). Qualitative analysis of the active fraction was 
given in Table 1 and Figure 4. The results clearly 
showed that active fraction may consist of indoles or 
terpenes or peptides. Finally, GC-MS were used for 
analyzing the chemical composition of the active 
fraction. A high percentage of the probability for five 
chemical compounds was noticed in the active fraction 
with peaks at 3.29, 7.98, 10.10, 12.69, 15.60, and 30.44 
RT. In the commercially available databases, the 
spectra of twenty-five peaks did not match, signifying 
the newness of these molecules (Table 2). 
 
Discussion 
The purpose of this study was to identify the active 
cyanobacterium among the marine isolates against 
pathogenic microbes and to select potential candidate 
for future research. In a similar study against 
Mycobacterium, the ethyl acetate extract of 
Aerococcus sp. was found to be active against  
M. smegematis with an inhibition zone of 8±0.1 
mm25. Mariita et al.26 reported antimycobacterial 
activity of MeOH extract of Entada abysinnica (2.0 
and 1.0 mg/ml) showed antimycobacterial activity 
against M. tuberculosis, M. fortuitum, and  
M. smegmatis. The cell-free extract of Nostoc 
muscorum Ag (U2301) and Fischerella ambiguia (Näg) 
Gom (U 1903) exhibited significant antimicrobial  
 
 
Fig. 2 — Cytotoxic activity of active fraction and extract of
G. carotinosum CNP 4003: Photomicrographs showing the effect
on untreated (Control), extract of G. carotinosum CNP 4003
(IC50 = 175 μg/ml) and active Fraction F6 of G. carotinosum




Fig. 3 — Hemolytic activity of active fraction 
Table 1 — Constituent analysis of active fraction of  
G. carotinosum CNP 4003 
Chemical Constituent (class) Indicating Reagent Results 
Sulfonamides, amines, indoles, 
and ergot alkaloids 
Ehrlich's reagent + 
Alkaloids Dragendorff's reagent − 
Peptides Ninhydrin + 
Phenolics Phenol reagent + 
Flavonoids 10% NaOH − 
Sterol Phosphomolybdate  + 
Anthraquinone 10% sodium hydroxide − 




+ indicates presence, − indicates absence 






Fig. 4 — Qualitative identification of compound classes in the active fraction of G. carotinosum CNP 4003: Extract was loaded on silica gel 
plates and developed with acetonitrile:heptane:chloroform (1:4.5:4.5 v/v/v) solvent mixture. After development, the plate was observed 
directly (Panel A) or under UV light at 254 nm (Panel B) or 366 nm (Panel C). Other plates were sprayed (and developed subsequently as 
outlined in Methods) with Anisaldehyde–H2SO4 (Panel D), 10 % KOH (Panel E), Ehrlich's (Panel F), ninhydrin (Panel G), Folin–Ciocalteu 
(Panel H), Ferric chloride (Panel I), anisaldehyde-HClO4 (Panel J), 10 % NaOH (Panel K) and Dragendorff's reagent (Panel L). Red arrow 
indicates presence of indoles (purple spot). Green arrow indicates presence of peptides (pink spot). Blue arrow indicates presence of terpenes 
(dark blue spot). 
 
Table 2 — Composition of active fraction of G. carotinosum CNP 4003 as revealed by gas chromatography mass spectrometry (GC-MS) 
Peak retention time (min) % of area Close match % of similarity 
3.29 75.66 Acetic acid, ethyl ester 93.50 
5.30 3.29 UI - 
7.98 0.30 1,3-Bis(4-chlorobenzyl)-5,6-dihydrobenzo[f]quinazoline 53.44 
10.10 0.32 Cycloheptasiloxane, tetradecamethyl 97.50 
12.69 0.23 Hexadecamethylcyclooctasiloxane 94.52 
14.54 0.13 UI - 
14.99 0.41 UI - 
15.60 0.18 Cyclononasiloxane, octadecamethyl 83.79 
18.35 0.25 UI - 
18.81 0.27 UI - 
19.81 3.07 Neophytadiene 38.91 
20.44 0.85 UI - 
20.81 1.77 3,7,11,15-Tetramethyl-2-hexadecen-1-ol 35.21 
22.88 0.41 UI - 
23.32 0.11 UI - 
23.95 8.63 Hexadecanoic acid 36.86 
25.05 0.21 UI - 
26.12 0.56 UI - 
26.70 0.23 UI - 
27.98 0.17 UI - 
29.42 0.12 UI - 
29.95 0.18 UI - 
30.44 1.15 5,10-Dihexyl-5,10-diihydroindolo[3,2-b]indole-2,7-dicarbaldehyde 58.52 
31.20 0.13 UI - 
32.44 0.16 UI - 
33.03 0.34 UI - 
33.73 0.11 UI - 
34.44 0.34 UI - 
38.23 0.15 UI - 
40.25 0.27 UI  
The data represents the relative area of the peaks in %. Peaks were identified by the NIST Mass Spectral library. Compounds that have a 
probability lower than 75 % to the closest match with the library are marked as unidentified (UI). 




activity  against  M.  tuberculosis27.  Extract  of  the 
cultured cyanobacterium Eucapsis sp. (UTEX 1519) 
exhibited the most potent activity (MIC 9.7 μg/ml) 
against M. tuberculosis28. Malyngolide isolated from 
L. majuscula showed potential antibacterial activity 
against M. smegmatis29. The active fraction of 
Hapalosiphon sp. displayed a minimum inhibitory 
concentration at 125-2000 µg/ml against strains of M. 
Tuberculosis30. Isolation of fischambiguine B from 
the cultured cyanobacterium, Fischerella ambigua 
(UTEX 1903) showed activity against M. tuberculosis 
with a MIC value of 2 μM and did not exhibit 
cytotoxicity on Vero cell line31. Brunsvicamide B 
from Tychonema sp. isolated from the pond of a sugar 
factory potentially inhibited M. tuberculosis enzyme 
MptpB with an IC50 value of 7.3 µM
32. Also 
Fischerella sp. isolated from Neem tree bark 
exhibited antimycobacterial activity against  
M. tuberculosis33.  
 
Among the 12 strains of cyanobacteria tested for 
antimicrobial activity, G. carotinosum CNP 4003 
showed better antimicrobial activity than the other 
strains. Extract of G. carotinosum CNP 4003 showed 
distinct antimicrobial activity against S. aureus ATCC 
25923, E. coli ATCC 35218, and M. smegmatis. 
Results of the hemolytic and cytotoxic activity of 
extract, and active fraction against human 
erythrocytes and HepG2 cell line showed its viability 
as a future drug candidate particularly for internal use. 
Bioactive molecules from marine cyanobacteria are 
well-known for their toxic effects against animals and 
some of the eukaryotic microbes. It is also reported 
that these structurally diverse antimicrobial 
compounds produced by cyanobacteria are discrete 
substances and differ from the cyanotoxins. 
Considering these properties, we have evaluated the 
cytotoxicity of the antimicrobial active extract against 
human erythrocytes and HepG2 cancer cells by 
hemolytic and MTT assay. This result demonstrated 
that the active fraction showed good 
antimycobacterial activity and high toxicity to human 
red blood cells and cancer cell lines. The assay 
indicated that the presence of toxic activity could be 
understood to the presence of cytotoxic activity for 
the active fraction. 
 
Compounds from cyanobacteria have been 
accounted for having different modes of antibacterial 
actions. Assessment of cyanobacteria peculiarly 
growing on black band disease of corals revealed the 
production of antibacterial compounds in them and also 
indicated that their activity depends mainly on 
ecological conditions34. Preliminary screening of 
organic and aqueous extracts of cyanobacteria, 
Anabaena strains, isolated from terrestrial environment 
exhibited antibacterial and cytotoxic activity35. Asthana 
et al.36 explored biochemical and antibacterial 
properties of Antarctic strain, Nostoc sp., and stated 
that antibacterial activity was specially connected with 
the habitat. Extracts from cyanobacterial mats of hot 
springs inhibited the growth of Klebsiella pneumoniae, 
Salmonella enteric, Micrococcus luteus, Shigella 
sonnei, Bacillus sp., Amphora coffeaeformis and QS of 
the reporter strain Chromobacterium violaceum CV017 
and Agrobacterium tumefaciens NTL437. Pramanik  
et al.38 reported the antimicrobial activity of 
cyanobacteria isolated from Sundarbans mangrove 
forest against P. aeruginosa, E. coli, B. subtilis, and  
S. aureus multiple drug-resistant clinical isolates  
(MIC 0.25-0.5 mg/ml). Furthermore, these extracts 
were shown to be nontoxic to human colon 
adenocarcinoma cell line at the same MIC value. 
Biomass extract of antibacterial activity of 
Geitlerinema sp. was recorded by Caicedo et al.39 and 
they further reported 100 % growth inhibition of 
Bacillus subtilis by the crude extract eluted with 
MeOH and isopropanol.  
 
Jaiswal et al.40 and Kim & Kim41 reported the 
antifungal activity of extracts from Microcystis 
aeruginosa and Nostoc commune FA-103 against the 
growth of phytopathogenic fungus, Fusarium 
oxysporum f. sp. lycopersici and Rhizoctonia solani. 
Another study demonstrated the antimicrobial potency 
of Nostoc strain ATCC 53789 against Sclerotinia 
sclerotiorum, Rosellinia sp, Penicillium expansum, and 
Armillaria sp at 0.25 g/l42. In an investigation by Pawar 
& Puranik43, methanolic extract of Oscillatoria limosa 
NMU-31 displayed a good antifungal activity against 
Aspergillus flavus with an inhibition zone of 28 mm 
diameter. Extracts obtained from Geitlerinema strain 
Flo1 by using Amberlite XAD-1180 resin exhibited 
activity against marine yeast, Rhodosporidium 
sphaerocarpum44. All these studies exposed the hidden 
novel antimycobacterial pharmacophores in marine 
cyanobacteria. Thus, it’s understood that the primary 
extracts of various species of marine cyanobacteria 
displayed promising antimycobacterial activity against 
Mycobacterium smegmatis. The purification of these 
crude extracts by different chromatographic techniques 
and structure elucidation by various spectroscopic 
analyses, such as IR, NMR, and MS is in progress. 





The results of the present study justified the 
promising antimycobacterial activity of the tested 
cyanobacterial crude extract. Further research is required 
to isolate, and identify the active principle(s) from 
cyanobacteria, and to evaluate their mode of action(s). 
The entire work specified at this point emphasize that 
the isolated cyanobacteria from the marine environment 
can be a potent antimicrobial agent.  
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